SCHEMBL7310366

SCHEMBL7310366

CC(C)C(=CCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.40
PPARG P37231 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA14 Q9ULX7 1/20 0.40
ATM Q13315 1/20 0.39
ITGA4 P13612 1/20 0.39
ITGB7 P26010 1/20 0.39
IDO1 P14902 1/20 0.39
TSHR P16473 1/20 0.38
AKT1 P31749 2/20 0.38
CTSS P25774 3/20 0.38
CTSK P43235 2/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CYP2C19 P33261 2/20 0.38
HIF1A Q16665 1/20 0.38
SLC7A5 Q01650 1/20 0.37
SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7310361 1.00 PPARA (0.40) PPARAPPARGCA12CA1CA7
SCHEMBL13762100 0.83 CA12 (0.42) PPARAPPARGCA12CA1CA7
SCHEMBL7299011 0.79 TSHR (0.42) TSHRCYP2C19ALDH1A1CYP2C9
SCHEMBL7299014 0.79 TSHR (0.42) TSHRCYP2C19ALDH1A1CYP2C9
SCHEMBL9574048 0.75 AKT1 (0.41) PPARAPPARGCA12CA1CA7
SCHEMBL9574045 0.75 AKT1 (0.41) PPARAPPARGCA12CA1CA7
SCHEMBL9574050 0.72 CA12 (0.40) PPARAPPARGCA12CA1CA7
SCHEMBL1880595 0.72 CA12 (0.44) PPARAPPARGCA12CA1CA7
Phenylacetaldehyde SCHEMBL28513708 0.72 CA12 (0.44) PPARAPPARGCA12CA1CA7
SCHEMBL7292665 0.72 ATM (0.47) CA12CA1CA7CA14ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed